20
https://pubmed.ncbi.nlm.nih.gov/38113974
CircPHKB reduces the sensitivity of liver cancer cells to sorafenib by sequestering miR-1234-3p and up-regulating CYP2W1, suggesting a potential target for improving sorafenib efficacy.